chr10-117241736-AGCCGCCGCTC-A
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_003054.6(SLC18A2):c.46_55del(p.Arg16GlyfsTer78) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 33)
Consequence
SLC18A2
NM_003054.6 frameshift
NM_003054.6 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.26
Genes affected
SLC18A2 (HGNC:10935): (solute carrier family 18 member A2) This gene encodes an transmembrane protein that functions as an ATP-dependent transporter of monoamines, such as dopamine, norepinephrine, serotonin, and histamine. This protein transports amine neurotransmitters into synaptic vesicles. Polymorphisms in this gene may be associated with schizophrenia, bipolar disorder, and other neurological/psychiatric ailments. [provided by RefSeq, Jun 2018]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.972 CDS is truncated, and there are 1 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 10-117241736-AGCCGCCGCTC-A is Pathogenic according to our data. Variant chr10-117241736-AGCCGCCGCTC-A is described in ClinVar as [Pathogenic]. Clinvar id is 2793810.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC18A2 | NM_003054.6 | c.46_55del | p.Arg16GlyfsTer78 | frameshift_variant | 2/16 | ENST00000644641.2 | NP_003045.2 | |
SLC18A2-AS1 | NR_184309.1 | n.113+139_113+148del | intron_variant, non_coding_transcript_variant | |||||
SLC18A2-AS1 | NR_184310.1 | n.151_160del | non_coding_transcript_exon_variant | 2/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC18A2 | ENST00000644641.2 | c.46_55del | p.Arg16GlyfsTer78 | frameshift_variant | 2/16 | NM_003054.6 | ENSP00000496339 | P1 | ||
SLC18A2-AS1 | ENST00000425264.2 | n.152_161del | non_coding_transcript_exon_variant | 2/3 | 3 | |||||
SLC18A2 | ENST00000497497.1 | n.189_198del | non_coding_transcript_exon_variant | 2/15 | 2 | |||||
SLC18A2-AS1 | ENST00000691914.2 | n.113+139_113+148del | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 31, 2022 | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with SLC18A2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg16Glyfs*78) in the SLC18A2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC18A2 are known to be pathogenic (PMID: 26539891, 31618753). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.